
Moderna has surged over 500% this year while its closest messenger RNA rival sits nearly flat, and a single late-October data presentation at ESMO could either cement the rally or erase it overnight.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Moderna has surged over 500% this year while its closest messenger RNA rival sits nearly flat, and a single late-October data presentation at ESMO could either cement the rally or erase it overnight.

Shorting the S&P 500 without a margin account sounds like a loophole, but the most popular tool for doing it carries a hidden cost that turns a decade of bearish bets into a slow-motion wipeout.

On Holding just did something it has never done before, and the stock is repricing fast. Whether today's surge marks a turning point or a trap depends on what management actually promised investors in Zurich.

SoFi stock just popped 5% while peers trade flat and the broader market barely budges, raising a question that cuts both ways: does that divergence signal a comeback or just a temporary bounce in a stock that has lost half its value this year?

Alibaba just unveiled a chip it claims reshapes the AI compute landscape inside China, and the stock is reacting sharply, but one key rival is barely moving, and that gap reveals exactly who the market thinks wins here.

Coretura just handed BlackBerry its first named design win for Alloy Kore, sending shares surging well past the broader software sector, but the deal comes with no contract value, no revenue timeline, and an earnings report less than 48 hours away.

Ryan Cohen just bought another million-plus shares of GameStop at a higher price than his purchase two weeks ago, yet the stock is barely moving. That gap between what the CEO is signaling and how the market is responding tells a complicated story about where GameStop goes from here.

Eli Lilly just posted a quarter that crushed estimates on every major metric, yet the stock has spent the past month getting punished anyway. One of Wall Street's biggest banks thinks the selloff created the most compelling entry point in the GLP-1 giant's recent history.

U.S. stock futures are showing a mixed-to-slightly-flat picture early Tuesday as Wall Street balances new U.S. sanctions targeting Iranian airlines against fresh corporate earnings reports and lingering market optimism from Monday’s AI-led rally. The Polymarket (CRYPTO: POL) crowd is leaning...

Opendoor Technologies (NASDAQ:OPEN) has posted a sharp monthly decline amid a small group of housing-linked names, and the bulls-versus-bears question in front of Opendoor shareholders is whether the drop reflects a housing-wide de-rating or something specific to the company. The iShares U.S. Home Construction ETF (NYSEARCA:ITB) is at $88.36, down 10% over the past month, […]

AMC's latest debt move shifts a key deadline further into the future, but whether that buys the struggling theater chain genuine breathing room or simply delays a reckoning depends on details the market is still pricing in.

A Cramer lightning-round call just sent BlackBerry shares surging ahead of a quarterly report that could either validate the QNX software story or unwind the entire move in a single session.

Mark Spitznagel, founder of Universa Investments, built his reputation protecting investors from market crashes. Now the Universa Investments founder says the S&P 500 will “easily” top 8,000 in one final euphoric rally before plunging 80%.SPDR S&P 500 ETF Trust (NYSE:SPY)...

A coveted Presidential Symposium slot at Europe's top oncology congress just sent Moderna shares flying 9%, but the actual Phase 3 melanoma data remains unseen. Here is why the scheduling alone is moving markets and what it signals about what that dataset might show.

Cantor Fitzgerald just restated its bull case for Rocket Lab with a $122 target, yet the stock is trailing a space peer that received no catalyst at all, and that disconnect tells you something important about what is actually driving Monday's rally.

Super Micro just posted a quarter that sent analyst price targets soaring and earnings estimates jumping by 30% in a single month, yet the stock still trades below those targets and insiders are quietly selling. The setup looks compelling until you dig into what management said about where those profits actually came from.

Stocks are popping and oil is dropping in early trading. Gold and silver are mixed, while Bitcoin and other cryptocurrencies are rising notably. The dollar is flat, while Treasury yields are retreating a bit.

Nuclear reactor developers are bouncing back Monday after last week's brutal selloff, but the bid is landing in a very specific corner of the sector, and the reason why reveals exactly how this trade is being played.

The S&P 500 Index ($SPX ) (SPY ) is up by +0.61% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.33%. December E-mini S&P futures (ESZ26 ) are up +0.70%, and December E-mini...

Nine straight earnings beats, a $147 billion cash fortress, and a stock climbing past every analyst target sounds like a no-brainer buy, but one lurking risk could make today's price look very expensive very fast.

Novo Nordisk took the stage at its own capital markets day and said something that sent its stock tumbling 7%, yet its closest rivals barely flinched. What the company revealed about its future tells investors exactly how much trouble the Ozempic empire may be in.

Antitrust settlement talks are reshuffling the media landscape in real time, sending two rival stocks surging for completely opposite reasons while their biggest streaming competitor barely flinches.

Microsoft is sitting on the biggest contracted backlog in its history while its stock trails the broader market by nearly 900 basis points, and the reason for that disconnect reveals everything about whether this setup is a trap or a buying opportunity.

Bitcoin just hit its highest level since January, and the equity complex is repricing fast but not evenly. Understanding why Strategy is outrunning the miners it resembles tells you everything about how these trades actually work.

A U.S.-Greenland security pact sent one small-cap rare earth stock soaring 25% at the open, but the deal contains a catch that changes nothing about what the company actually owns or produces.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.